Innate Immunity to Pulmonary Infection (eBook)
238 Seiten
John Wiley & Sons (Verlag)
978-0-470-03538-2 (ISBN)
uniquely addresses the use of innate immunity to treat or prevent
infectious diseases of the lung.
Innate Immunity to Pulmonary Infection:
* Provides a comprehensive overview of pulmonary infectious
diseases, including basic pathology, current and potential
therapies, and detailed consideration of the innate biological
resistance mechanisms in the lung
* Thoroughly examines the major topic of innate immunity in
immunology, which is now seen as key to the pathogenesis of and
vaccination strategies for infectious diseases
* Describes the genetic and environmental factors which determine
the outcome of infection, such as latency of Tuberculosis, blood
stream invasion from local infection, and local target tissue
damage
* Covers the roles of cells such as neutrophils, macrophages and
dendritic cells and of molecular components such as Toll-like
receptors
* Discusses the clinical applications of the new knowledge
regarding innate immunity and how this can be used in both
treatment and prevention (vaccination) strategies
* Includes contributions from an international and
interdisciplinary group of experts
Innate Immunity to Pulmonary Infection is an
essential resource for researchers in both industry and academia.
It is of interest for all those interested in the disciplines of
immunology, virology, biology, biotechnology and genetics.
The Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research.
Symposium on Innate immunity to pulmonary infection, held at the
Wolfson Pavillion, University of Cape Town Medical School, South
Africa, 28-30 November 2005.
Editors: Derek J. Chadwick (Organizer) and Jamie
Goode.
This symposium is based on a proposal made by Siamon Gordon and
Gordon Brown.
Chair's introduction (Siamon Gordon).
Lung diseases in South Africa: an overview (Eric D.
Bateman and Anamika Jithoo).
Discussion.
TB epidemiology and human genetics (Paul D. van Helden, Marlo
Moller, Chantal Babb, Robin Warren, Gerhard Walzl, Pieter Uys
and Eileen Hoal).
Discussion.
Bacterial infections of the lung in normal and immunodeficient
patients (David P. Speert).
Discussion.
Pathogenesis of avian flu H5N1 and SARS (Malik
Peiris).
Discussion.
Immunity and tolerance to Aspergillus fumigatus
(Claudia Montagnoli, Silvia Bozza, Roberta Gaziano, Teresa
Zelante, Pierluigi Bonifazi, Francesca Sepioni, Silvia Bellocchio,
Lucia Pitzurra and Luigina Romani).
Discussion.
Pentraxins in innate immunity and inflammation (Cecilia
Garlanda, Barbara Bottazzi, Giovanni Salvatori, Rita De Santis,
Alessia Cotena, Livija Deban, Viriginia Maina, Federica Moalli,
Andrea Doni and Alberto Mantovani).
Discussion.
How superoxide production by neutrophil leukocytes kills
microbes (Anthony W. Segal).
Discussion.
Linking innate to adaptive immunity through dendritic cells
(Ralph M. Steinman).
Discussion.
Macrophage receptors and innate immunity: insights from dectin-1
(Gordon D. Brown).
Discussion.
Toll-like receptors and control of mycobacterial infection in
mice (Bernhard Ryffel, Muazzam Jacobs, Shreemanta Parida, Tania
Botha, Dieudonnée Togbe and Valerie
Quesniaux).
Discussion.
Population of lungs by mast cells (T. J. Williams and
C. L. Weller).
Discussion.
Innate immunity and mucus structure and function (John K.
Sheehan, Mehmet Kesimer and Raymond Pickles).
Discussion.
Collectins and host defence (R. B. Sim, H. Clark, K.
Hajelaand K. R. Mayilyan).
Discussion.
Infections and asthma pathogenesis: a critical role for
dendritic cells? (Bart N. Lambrecht and Leonie S. van
Rijt).
Discussion.
Innate and adaptive immunity in lung cancer (L. A. Vella
and O. J. Finn).
Discussion.
Summing up (Siamon Gordon).
Index of Contributors.
Subject index.
"...substantially elucidating recent basic science observations of potentially remarkable importance in understanding human biology." (Doody's Health Services)
Erscheint lt. Verlag | 11.1.2007 |
---|---|
Reihe/Serie | Novartis Foundation Symposium |
Sprache | englisch |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie |
Medizinische Fachgebiete ► Innere Medizin ► Pneumologie | |
Studium ► Querschnittsbereiche ► Infektiologie / Immunologie | |
Naturwissenschaften ► Biologie | |
Technik ► Umwelttechnik / Biotechnologie | |
Schlagworte | Biochemie • biochemistry • Biowissenschaften • clinical microbiology • Immunologie • immunology • Klinische Mikrobiologie • Life Sciences • Medical Science • Medizin • Mikrobiologie |
ISBN-10 | 0-470-03538-2 / 0470035382 |
ISBN-13 | 978-0-470-03538-2 / 9780470035382 |
Haben Sie eine Frage zum Produkt? |
Größe: 7,7 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich